Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
28
pubmed:dateCreated
2009-9-30
pubmed:databankReference
pubmed:abstractText
We sought to improve outcomes for patients with high-risk head and neck squamous cell cancer (HNSCC) after surgical resection by testing the feasibility and safety of early postoperative chemotherapy followed by concurrent chemoradiotherapy.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4727-32
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19720915-Adult, pubmed-meshheading:19720915-Aged, pubmed-meshheading:19720915-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19720915-Carcinoma, Squamous Cell, pubmed-meshheading:19720915-Cisplatin, pubmed-meshheading:19720915-Combined Modality Therapy, pubmed-meshheading:19720915-Feasibility Studies, pubmed-meshheading:19720915-Female, pubmed-meshheading:19720915-Follow-Up Studies, pubmed-meshheading:19720915-Head and Neck Neoplasms, pubmed-meshheading:19720915-Humans, pubmed-meshheading:19720915-Kaplan-Meier Estimate, pubmed-meshheading:19720915-Male, pubmed-meshheading:19720915-Middle Aged, pubmed-meshheading:19720915-Paclitaxel, pubmed-meshheading:19720915-Radiotherapy, pubmed-meshheading:19720915-Skin Diseases, pubmed-meshheading:19720915-Time Factors, pubmed-meshheading:19720915-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024.
pubmed:affiliation
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. dirosenthal@mdanderson.org
pubmed:publicationType
Journal Article, Clinical Trial, Phase II, Research Support, N.I.H., Extramural